Match!

Induction of HIV Neutralizing Antibody Lineages in Mice with Diverse Precursor Repertoires.

Published on Sep 8, 2016in Cell36.216
· DOI :10.1016/J.CELL.2016.07.029
Ming Tian17
Estimated H-index: 17
(Harvard University),
Cheng Cheng23
Estimated H-index: 23
(Vaccine Research Center)
+ 37 AuthorsFrederick W. Alt156
Estimated H-index: 156
(Harvard University)
Sources
Abstract
The design of immunogens that elicit broadly reactive neutralizing antibodies (bnAbs) has been a major obstacle to HIV-1 vaccine development. One approach to assess potential immunogens is to use mice expressing precursors of human bnAbs as vaccination models. The bnAbs of the VRC01-class derive from the IGHV1-2 immunoglobulin heavy chain and neutralize a wide spectrum of HIV-1 strains via targeting the CD4 binding site of the envelope glycoprotein gp120. We now describe a mouse vaccination model that allows a germline human IGHV1-2∗02 segment to undergo normal V(D)J recombination and, thereby, leads to the generation of peripheral B cells that express a highly diverse repertoire of VRC01-related receptors. When sequentially immunized with modified gp120 glycoproteins designed to engage VRC01 germline and intermediate antibodies, IGHV1-2∗02-rearranging mice, which also express a VRC01-antibody precursor light chain, can support the affinity maturation of VRC01 precursor antibodies into HIV-neutralizing antibody lineages.
  • References (40)
  • Citations (102)
📖 Papers frequently viewed together
201536.22Cell
162 Citations
201541.06Science
18 Authors (Joseph G. Jardine, ..., David Nemazee)
206 Citations
201636.22Cell
151 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
References40
Newest
#1Sherry G. Lin (Harvard University)H-Index: 3
#2Zhaoqing Ba (Harvard University)H-Index: 3
Last. Frederick W. Alt (Harvard University)H-Index: 156
view all 6 authors...
Developing B lymphocytes undergo V(D)J recombination to assemble germ-line V, D, and J gene segments into exons that encode the antigen-binding variable region of Ig heavy (H) and light (L) chains. IgH and IgL chains associate to form the B-cell receptor (BCR), which, upon antigen binding, activates B cells to secrete BCR as an antibody. Each of the huge number of clonally independent B cells expresses a unique set of IgH and IgL variable regions. The ability of V(D)J recombination to generate v...
27 CitationsSource
#1Dennis R. Burton (Scripps Research Institute)H-Index: 142
#2Lars Hangartner (Scripps Health)H-Index: 22
HIV employs multiple means to evade the humoral immune response, particularly the elicitation of and recognition by broadly neutralizing antibodies (bnAbs). Such antibodies can act antivirally against a wide spectrum of viruses by targeting relatively conserved regions on the surface HIV envelope trimer spike. Elicitation of and recognition by bnAbs are hindered by the arrangement of spikes on virions and the relatively difficult access to bnAb epitopes on spikes, including the proximity of vari...
251 CitationsSource
#1Brandon J. DeKosky (University of Texas at Austin)H-Index: 16
#2Oana I. Lungu (University of Texas at Austin)H-Index: 8
Last. George Georgiou (University of Texas at Austin)H-Index: 81
view all 11 authors...
Elucidating how antigen exposure and selection shape the human antibody repertoire is fundamental to our understanding of B-cell immunity. We sequenced the paired heavy- and light-chain variable regions (VH and VL, respectively) from large populations of single B cells combined with computational modeling of antibody structures to evaluate sequence and structural features of human antibody repertoires at unprecedented depth. Analysis of a dataset comprising 55,000 antibody clusters from CD19+CD2...
94 CitationsSource
#1Jiazhi Hu (Boston Children's Hospital)H-Index: 12
#2Robin M. Meyers (Boston Children's Hospital)H-Index: 18
Last. Richard L. Frock (Boston Children's Hospital)H-Index: 15
view all 6 authors...
This protocol describes a genome-wide method to detect and to quantify DNA double-stranded breaks (DSBs). The approach is applicable to endogenous DSBs, but it can also be used to characterize the activity of engineered nucleases, including Cas9.
81 CitationsSource
#1Leopold Kong (Scripps Research Institute)H-Index: 29
#1Leopold Kong (Scripps Research Institute)H-Index: 1
Last. Yiming Shao (PKU: Peking University)H-Index: 4
view all 28 authors...
Summary VRC01-class antibodies neutralize diverse HIV-1 strains by targeting the conserved CD4-binding site. Despite extensive investigations, crucial events in the early stage of VRC01 development remain elusive. We demonstrated how VRC01-class antibodies emerged in a Chinese donor by antigen-specific single B cell sorting, structural and functional studies, and longitudinal antibody and virus repertoire analyses. A monoclonal antibody DRVIA7 with modest neutralizing breadth was isolated that d...
46 CitationsSource
#1Mattia Bonsignori (Duke University)H-Index: 34
#2Tongqing Zhou (NIH: National Institutes of Health)H-Index: 47
Last. Barton F. HaynesH-Index: 124
view all 51 authors...
Summary Antibodies with ontogenies from V H 1-2 or V H 1-46-germline genes dominate the broadly neutralizing response against the CD4-binding site (CD4bs) on HIV-1. Here, we define with longitudinal sampling from time-of-infection the development of a V H 1-46-derived antibody lineage that matured to neutralize 90% of HIV-1 isolates. Structures of lineage antibodies CH235 (week 41 from time-of-infection, 18% breadth), CH235.9 (week 152, 77%), and CH235.12 (week 323, 90%) demonstrated the maturin...
167 CitationsSource
#1Joseph G. Jardine (Scripps Research Institute)H-Index: 14
#2Daniel W. Kulp (Scripps Research Institute)H-Index: 27
Last. William R. SchiefH-Index: 54
view all 22 authors...
Induction of broadly neutralizing antibodies (bnAbs) is a major HIV vaccine goal. Germline-targeting immunogens aim to initiate bnAb induction by activating bnAb germline precursor B cells. Critical unmet challenges are to determine whether bnAb precursor naive B cells bind germline-targeting immunogens and occur at sufficient frequency in humans for reliable vaccine responses. Using deep mutational scanning and multitarget optimization, we developed a germline-targeting immunogen (eOD-GT8) for ...
190 CitationsSource
#1Andrew T. McGuire (Fred Hutchinson Cancer Research Center)H-Index: 12
#2Matthew D. Gray (Fred Hutchinson Cancer Research Center)H-Index: 8
Last. Leonidas Stamatatos (UW: University of Washington)H-Index: 42
view all 16 authors...
VRC01-class broadly neutralizing HIV-1 antibodies protect animals from experimental infection and could contribute to an effective vaccine response. Their predicted germline forms (gl) bind Env inefficiently, which may explain why they are not elicited by HIV-1 Env-immunization. Here we show that an optimized Env immunogen can engage multiple glVRC01-class antibodies. Furthermore, this immunogen activates naive B cells expressing the human germline heavy chain of 3BNC60, paired with endogenous m...
96 CitationsSource
#1Jiazhi Hu (Harvard University)H-Index: 12
#2Yu Zhang (Harvard University)H-Index: 44
Last. Frederick W. Alt (Harvard University)H-Index: 156
view all 9 authors...
Summary RAG initiates antibody V(D)J recombination in developing lymphocytes by generating "on-target" DNA breaks at matched pairs of bona fide recombination signal sequences (RSSs). We employ bait RAG-generated breaks in endogenous or ectopically inserted RSS pairs to identify huge numbers of RAG "off-target" breaks. Such breaks occur at the simple CAC motif that defines the RSS cleavage site and are largely confined within convergent CTCF-binding element (CBE)-flanked loop domains containing b...
84 CitationsSource
#1Joseph G. Jardine (International AIDS Vaccine Initiative)H-Index: 14
#2Takayuki Ota (Scripps Research Institute)H-Index: 28
Last. David Nemazee (Scripps Research Institute)H-Index: 59
view all 18 authors...
206 CitationsSource
Cited By102
Newest
#1Zhui TuH-Index: 12
#2Xiaoqiang Huang (UM: University of Michigan)H-Index: 8
Last. Yang Zhang (UM: University of Michigan)H-Index: 60
view all 7 authors...
Source
#1Samuel Schmitz (Vandy: Vanderbilt University)H-Index: 1
#2Cinque Soto (VUMC: Vanderbilt University Medical Center)H-Index: 3
Last. Jens Meiler (Vandy: Vanderbilt University)H-Index: 52
view all 4 authors...
The antibody (Ab) germline gene rearrangement of variable (V), diversity (D), and joining (J) gene segments, as well as somatic hypermutation, give rise to the human Ab variable gene sequence reper...
Source
#1Huan Chen (Harvard University)H-Index: 1
#2Yuxiang Zhang (Harvard University)H-Index: 14
Last. Donna Neuberg (Harvard University)H-Index: 121
view all 12 authors...
The antigen-binding variable regions of the B cell receptor (BCR) and of antibodies are encoded by exons that are assembled in developing B cells by V(D)J recombination1. The BCR repertoires of primary B cells are vast owing to mechanisms that create diversity at the junctions of V(D)J gene segments that contribute to complementarity-determining region 3 (CDR3), the region that binds antigen1. Primary B cells undergo antigen-driven BCR affinity maturation through somatic hypermutation and cellul...
2 CitationsSource
#1Vivek Hariharan (Georgia Institute of Technology)H-Index: 1
#2Ravi S. Kane (Georgia Institute of Technology)H-Index: 49
The discovery of broadly neutralizing antibodies that can neutralize multiple strains or subtypes of a pathogen has renewed interest in the development of broadly protective vaccines. To that end, there has been an interest in designing immunofocusing strategies to direct the immune response to specific, conserved regions on antigenic proteins. Modulation of glycosylation is one such immunofocusing strategy; extensive glycosylation is often exploited by pathogens for immune evasion. Masking epit...
Source
#1Ming Tian (Harvard University)H-Index: 17
#2Kelly McGovern (Harvard University)H-Index: 1
Last. Nicole Manfredonia (Harvard University)
view all 15 authors...
HIV-1 vaccine development aims to elicit broadly neutralizing antibodies (bnAbs) against diverse viral strains. In some HIV-1–infected individuals, bnAbs evolved from precursor antibodies through affinity maturation. To induce bnAbs, a vaccine must mediate a similar antibody maturation process. One way to test a vaccine is to immunize mouse models that express human bnAb precursors and assess whether the vaccine can convert precursor antibodies into bnAbs. A major problem with such mouse models ...
Source
#1Deli Huang (Scripps Research Institute)H-Index: 6
#2Robert K. AbbottH-Index: 5
Last. Theresa C. Thinnes (Scripps Research Institute)H-Index: 1
view all 21 authors...
Animal models of human antigen-specific B cell receptors (BCR) generally depend on "inferred germline" sequences, and thus their relationship to authentic naive human B cell BCR sequences and affinities is unclear. Here, BCR sequences from authentic naive human VRC01-class B cells from healthy human donors were selected for the generation of three new BCR knock-in mice. The BCRs span the physiological range of affinities found in humans, and use three different light chains (VK3-20, VK1-5, and V...
1 CitationsSource
#1Todd BradleyH-Index: 16
Last. Robert Parks (Duke University)H-Index: 38
view all 30 authors...
Eliciting protective titers of HIV-1 broadly neutralizing antibodies (bnAbs) is a goal of HIV-1 vaccine development, but current vaccine strategies have yet to induce bnAbs in humans. Many bnAbs isolated from HIV-1-infected individuals are encoded by immunoglobulin gene rearrangments with infrequent naive B cell precursors and with unusual genetic features that may be subject to host regulatory control. Here, we administer antibodies targeting immune cell regulatory receptors CTLA-4, PD-1 or OX4...
3 CitationsSource
#1Andrey Galkin (UMD: University of Maryland, College Park)H-Index: 4
#1Andrey Galkin (UMD: University of Maryland, College Park)H-Index: 23
Last. Nicole A. Doria-Rose (NIH: National Institutes of Health)H-Index: 38
view all 13 authors...
Elicitation of broadly neutralizing Ab (bNAb) responses toward the conserved HIV-1 envelope (Env) CD4 binding site (CD4bs) by vaccination is an important goal for vaccine development and yet to be achieved. The outcome of previous immunogenicity studies suggests that the limited accessibility of the CD4bs and the presence of predominant nonneutralizing determinants (nND) on Env may impede the elicitation of bNAbs and their precursors by vaccination. In this study, we designed a panel of novel im...
Source
#1Luka Mesin (Rockefeller University)H-Index: 11
#2Ariën Schiepers (Rockefeller University)H-Index: 3
Last. Gabriel D. Victora (Rockefeller University)H-Index: 30
view all 9 authors...
Summary Repeated exposure to pathogens or their antigens triggers anamnestic antibody responses that are higher in magnitude and affinity than the primary response. These involve reengagement of memory B cell (MBC) clones, the diversity and specificity of which determine the breadth and effectiveness of the ensuing antibody response. Using prime-boost models in mice, we find that secondary responses are characterized by a clonality bottleneck that restricts the engagement of the large diversity ...
8 CitationsSource
#1Ming Tian (Boston Children's Hospital)H-Index: 17
#2Kelly McGovern (Boston Children's Hospital)
Last. Frederick W. Alt (Boston Children's Hospital)H-Index: 156
view all 15 authors...
HIV-1 vaccine development aims to elicit broadly neutralizing antibodies (bnAbs) against diverse viral strains. In some HIV-1 infected individuals, bnAbs evolve from precursor antibodies through affinity maturation. To induce bnAbs, a vaccine must mediate a similar process of antibody maturation. One way to test vaccination strategies is to immunize mouse models that express human bnAb precursors. Such immunization experiments can assess whether the vaccine can convert precursor antibody into bn...
Source